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Introduction. The purpose of this paper is to
review the endocrinologic evaluation of 58 patients
who presented to our institution this past year with a
chief complaint of absent or irregular menses. The
primary goal for presenting these patients is to review
the results of several newer studies as well as older
and more classical studies which are useful in the
differential diagnosis of amenorrhea. Such newer
studies not only take advantage of the more current
knowledge of the ovulatory process but also utilize
recently developed and highly sensitive techniques or
hormonal assay. It is hoped that this will provide the
reader with some suggestions for a current and
efficient method to evaluate the several causes or
amenorrhea.
Materials and Methods. Amenorrhea is usually
categorized as being either primary or secondary. and
the patient's age or duration of absent menses varies
among the several definitions available. For the pur
pose of this paper the following definitions will be
utilized:
Primary Amenorrhea. Failure to have initiated
menstrual bleeding by age 18.
Secondary Amenorrhea. Cessation of previously
established menses for an interval of more than one
year.
0/igomenorrhea. Spontaneous, irregular menses
* Presented by Dr. Hammond al the 46th Annual McGuire
Lecture Series. December 5. 1974. al the Medical College of
Virginia, Richmond.
** Supported by a grant (RR-30) rrom the General Clinical
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occurring at intervals of not less than three months.
Fifty-eight patients were studied and were divid
ed into three major diagnostic categories according to
their presenting menstrual patterns. Eight patients
had primary amenorrhea, forty-six had secondary
amenorrhea. and four patients had oligomenorrhea.
Other patients with demonstrable uterine causes of
amenorrhea are excluded from this study. This in
cluded patients with Asherman's syndrome, miil
lerian abnormalities in which no uterus was pres
ent. and testicular-feminization patients. Thus, all
patients included had uteri capable of normal
menstruation, and this was evidenced by proges
terone-induced withdrawal bleeding, endometrial bi
opsy, estrogen-progesterone withdrawal bleeding,
and/or hysterosalpingogram. Patients with easily diag
nosable abnormalities of thyroid or adrenal function
also are not included, as early outpatient studies usually
revealed the etiology of their amenorrhea and ap
propriate therapy resulted in prompt return of menstrual
function. For these reasons one can not draw valid
incidence frequencies from this referral-practice popula
tion of 58 amenorrheic patients.
S1udies Performed. All 58 patients were
hospitalized on the Clinical Research Ward of our
institution and underwent study. Tests included
a thorough general and endocrine history, com
plete physical and pelvic examination, Papanicolaou
smear. vaginal cytologic maturation index. complete
blood count. urinalysis. Chem- I 8. anteroposterior
(AP) and lateral skull x-rays. chest x-ray. and visual
fields by perimeter.
All 58 patients also underwent a series or
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baseline and dynamic hormonal testing. Serum total
estrogen (I). progesterone (2), follicle stimulating
hormone (FSH) (3). luteinizing hormone (LH) (4),
I and growth hormone (5) were all performed in
duplicate by standard radioimmunoassay techniques.
Serum prolactin was initially done in the labora
tory or Dr. Henry Friesen and later by Dr. Stuart
Handwerger, both using radioimmunoassay (6).
Serum T, and T3 Uptake were done by standard
techniques, as were urinary 17-hydroxycorlicoids and
17-ketosteroids.
All patients also underwent the following three
dynamic tests of pituitary function:
I. Hypoglycemia was induced by the intra
venous administration of 0.1 units insulin per
kilogram with blood glucose and human growth hor
mone (radioimmunoassay) determined at intervals
over 90 minutes. Blood glucose had to achieve at least
50% reduction from fasting levels to be considered an
adequate stimulus for the release of growth hormone.
A positive growth hormone response to insulin
induced hypoglycemia consisted of a peak value or
growth hormone greater than IO ng/ml (7).
2. Control 24-hour urine collections were ob
tained for 17-hydroxycorticoids (170H) and 17ketosteroids (I 7KS). If normal hydroxycorticoids
were present. the patient was then given
Metopirone". 750 mg orally every 4 hours for 6
doses. After the last dose of Metopirone•. another
24-hour urine collection was made. A normal re
sponse of pituitary ACTH was considered present
if the levels of 17-hydroxycorticoids doubled (8).
3. The ability to release gonadotropins was
tested with LH-FSH Releasing Hormone. Baseline
FSH and LH were determined. then the patients
received 100 µg SC of AY 24031, Ayerst Labora
tories LH-FSH Releasing Hormone. Blood samples
were then taken at frequent intervals over a period
of 6 hours, and duplicate samples were assayed by
radioimmunoassay for FSH and LH. Serum total
estrogens were determined by radioimmunoassay on
the control and 6-hours samples. Currently we are
evaluating a variety of response parameters. and we
realize that our own criteria for a positive response
may be altered. However, in the interim. a positive
response to LH-FSH Releasing Hormone was con
sidered present if both serum LH rose by more than
fourfold over baseline and serum FSH at least
doubled (9).
Other Studies. As patients were evaluated by the
techniques listed previously, many were found to
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have significant abnormalities which required further
investigation. Such studies included:
Patients with prolactin excess (on duplicate
samples) usually underwent further testing of prolac
tin kinetics with L-dopa, chlorpromazine, water load,
and other studies. If the excess secretion was not
readily explainable. then sella turcica tomography
and pneumoencephalography were usually per
formed.
Evidence or clinical androgen excess or signifi
cant laboratory documentation of this usually led to
determination of serum testosterone, urinary
pregnanetriol. and appropriate dexamethasone sup
pression. If an ovarian source was presumed, then
laparoscopy and ovarian biopsy were carried out.
Elevated 17-hydroxycorticoids led to the deter
mination of plasma cortisol and dexamethasone sup
pression. with pituitary evaluation if pituitary tumor
was suspected.
Abnormal thyroid function was evaluated by
traditional methodology.
Patients who had stigmata of gonadal dysgene
sis. or primary amenorrhea which seemed of gonadal
origin (such as evidenced by elevated gonadotropins),
were then evaluated by buccal smear and karyotype
of peripheral leukocytes. If there was evidence or
signif-icant early estrogen production or a "Y"
chromosome on karyotype. then laparoscopy and
gonadal biopsy with both histopathologic study and
gonadal karyotype were done. Gonads with "Y"
chromosome were surgically removed.
If patients had abnormal skull x-rays or signifi
cant endocrinologic evidence of hypopituitarism or
pituitary tumor. then tomograms of the sella turcica,
pneumoencephalography. and/or carotid arteriography
were performed.
Once a diagnosis was achieved. appropriate
therapy was carried out. No patient suffered any
significant side effects from any of these diagnostic
studies.
Results. After these 58 patients had completed
the previously listed diagnostic studies. a final
diagnosis was assigned. The tables which follow
(Tables I. 2. 3) are each arranged with patients
grouped by these final diagnoses and the results
of the various diagnostic tests listed below. In this
fashion one can not only study the results of the
several tests performed in patients with a particular
cause of amenorrhea but also evaluate how a specific
test may provide useful data in the several groups of
patient diagnoses.
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TABLE I
Primary Amenorrhea

( 8 Patients)

Diagnosis

(No.)

Family Hx.

Constitutional
Delay
(3)

Hypothalamic

+

-

Cause
(2)

?Congcnit..tl

Gonadal

Abscncc LH
(2)

Dysgenesis
(I)

Estrogen

I

J sl.

I

I

FSH-LH

FSH-Normal
LH-sl. I

FSH-Normal
LH-sl. I

FSH-Normal
LH-sl. I

II

-

-

-

-

FSH +
LH +

FSH +
LH +

FSH +
LH -

FSH +
LH +

lnsulin-HGH

+

+

+

+

Metopirone k

+

+

+

+

HGH. Prolactin.
170H. 17KS.
Thyroid
LRH Test

+ positive response. or normal test result.
- negative response. or reduced test result.
(See lex! for details.)

Primary Amenorrhea (Table I). Eight patients
presented with primary amenorrhea. Three patients
were felt to have constitutional delay of menarche.
Family history was positive in all three patients, and.
while all had had a sequential development of secon
dary sex characteristics. all had reduced estrogen
levels. Levels of FSH were normal and LH levels
were minimally elevated in all three patients. Baseline
testing of other hormones was normal. There was a
significant response in all patients to LH Releas
ing Hormone, Insulin-Growth Hormone, and Met
opirone®. The patients' ages were 18, 19, and 23
years. All have subsequently begun spontaneous
menses.
Similar findings to those mentioned in the
previous category were present in the testing of two
patients thought to have "hypothalamic" primary
amenorrhea. except there was no family history of
delayed menarche.
Two patients had low baseline serum LH and
failed to elevate LH in response to LH-Releasing
Hormone on either of two occasions. This suggested
lo us a reduced ability to produce, or release, or a
congenital diminution in LH.
Finally, one patient had Turner's syndrome
(gonadal dysgenesis) which was proven by karyotype.
Serum FSH was quite high, but there still existed a
capacity of the pituitary to increase gonadotropin
release when LH-Releasing Hormone was given.

Secondary Amenorrhea-Organic (Table 2). Six
teen patients presented with secondary amenorrhea
which was finally shown to be of an organic etiology.
Four patients had pituitary tumors; one, a
patient with a microadenoma and hyperprolac
tinemia. one with clinical signs of acromegaly. Three
of the four patients had abnormal skull x-rays and
reduced estrogen production. Two patients had
significantly low gonadotropin values. Baseline hor
monal testing revealed an elevation of growth hor
mone in the patient with acromegaly. Other baseline
testing was normal. Two of the four patients failed to
have an adequate response by LH (one borderline,
however) while two had a positive response of FSH
to LH-Releasing Hormone. One of the four patients
had a negative growth hormone test. All had surgical
ly proven lesions.
Two patients had craniopharyngiomas. Both
had positive skull x-rays and decreased estrogen and
gonadotropins. One patient had reduced baseline 17hydroxycorticoids. One patient had a modest
response to LH-Releasing Hormone while the other
had no response. Neither patient responded to
lnsulin-HGH testing. Metopirone® testing was not
done in one patient. but ACTH testing was normal.
Two patients had the "empty sella" syndrome.
Again. skull x-rays were abnormal in both patients
and estrogen and gonadotropins were low. Other
baseline hormonal testing was normal. Both patients
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responded to Insulin-HGH and Metopirone'''. but
one patient responded poorly to LH-Releasing
Hormone. Both patients had this diagnosis con
firmed by pneumoencephalography.
Two patients had Sheehan's syndrome with
postpartum pituitary necrosis. One patient was
clinically panhypopituitary. finding conf-irmed by low
test results of estrogen, gonadotropins. thyroid, and
adrenal function. Neither patient responded positive
ly with both LH and FSH to LH-Releasing Hormone
or Insulin-HGH. Metopirone• testing was not per
formed when low serum cortisols were detected.
Adrenal response to ACTH was normal.
Four patients had clinical signs of androgen ex
cess with significant hirsutism. Clinical estrogeniza
tion was good in all four. but, while ba:;eline FSH
was normal, the baseline LH was mildly elevated in
all. Laboratory evidence of excess androgen was pres
ent in all four patients and was reflected by elevated
17-ketosteroids. Serum testosterone was elevated in
two patients with Stein-Leventhal syndrome. and
pregnanetriols were elevated in the other two patients

Diagnosis
(No.)
P. Exam

Skull x-ray
Estrogen
FSH-LH
HGH. Prolactin, 170H.
I 7KS. Thyroid
LRH Test
lnsulin-HGH
M e1opi rone�

PituitcJry

Tumor

who were felt to have adult-onset adrenogenital syn
drome. In all four patients there was a normal
response of FSH to LH-Releasing Hormone, but an
impaired LH response. Other testing was normal.
There were l wo other patients with organic
causes of secondary amenorrhea, one with
hypothyroidism and one with premature ovarian
failure. Test n::sults are as listed.
Secondary A 111enorrhea-Functional (Table 3 ).
Thirty patients had secondary amenorrhea which was
felt to be of functional etiology. Patients are divided
into diagnoses of anorexia nervosa (4 patients) and
"hypothalamic" causes (26 patients). This latter large
group is subdivided into patients who had rapid
weight loss or gain. stable weight. or had developed
amenorrhea after utilizing oral contraceptives. Skull
x-rays and physical examinations were negative ex
cept for that of weight change. and for four patients
who had galactorrhea.
All patients with anorexia nervosa and
hypoestrogenism had decreased gonadotropins.
Thyroid function was reduced slightly in two

TABLE 2
Secondarv0 Amenorrhea-Organic
( 16 Patients)
""Empty . .
CranioSella
pharyngioma

Androgen
Exct:ss

Shct!han·:-.

(2)

(2)

(2)

(4)

Acromegaly
(I)
Galactorrhea
(I)
+(3)
I (31
! (2 )

V. Fields ( 11

-

Hvpopit. (I)

Hirsutism (4)

+
I
I

+

-

Normal

HGHJ (II

170HJ (II

Normal

(4)

Pro lac-

tin j ( 11
FSH +2
LH +2
(Ii
+

!

-(I)

sl. I (II

-

+
+

Others:
Hypothyroid ( 1)-Galactorrhea: decreased estrogen. FSH. LH. thyroid :-.llldic�.
Other testing normal.
Prem..iture Ovarian Failure (I)-Decreased estrogen: elevated �SH and LH.
Other testing normal.
+ positive response. or normal test result.
- negative response. or reduced test result.

(Sec text for details.)

s� ndrvtllt!

I
I
170H It Ii
Thyroid J ( 11
-

(II
-

FSH Normal
LH I (4)
J 17KS (41
J Tcstos. (2)
j !'Trio! (21
FSH+
LH+
+
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TABLE 3
Secondary Amenorrhea-Functional
( 30 Patients)

Anorexia

"HYPOTHALAMIC CAUSES" (26)

Nervosa
(4)

Rapid wgt.
Loss(4)

Skull x-ray
P. Exam

-

-

Estrogen
FSH-LH

Diagnosis
(No.)

HGH. Pro-

Rapid wgt.
Gain(3)

Stable wgt.
( 15)

"Post Pill"
(4)

Galactorrhea
(.l)

Galactorrhea
(I)

Group Total
(26)
(4)

!

j(I)

Normal

(4)

(2)

J (7)

J

J (3)

J (2)

,l.j (2)

J (2)

sLJ (2)
J (7)

Thyroid sl.

Normal

Normal

Thyroid sl.

Prolactin

Thyroid! (3)

l (3)

1(1)

Prolactin I(I)
++(5)
sl. J (7)

lactin. 170H.
17KS. thyroid

l (2)

LRH Test

-(3)

-(3)

-(IJ

I +(5)
sl.J (6)

(IJ
sl.j(IJ

lnsulin-HGH

+

-(I)

+

+

+

(I)

Metopirone"

+

+

+

+

+

+

- (5)

+ positive response. or normal test result.
- negative response. or reduced test result.

patients. Three of the four patients failed lo respond
to LH-Releasing Hormone, but all patients had nor
mal responses lo insulin by growth hormone and to
Metopirone•.
The four patients with rapid weight loss. but not
anorexia nervosa. showed better estrogenization. but
low gonadotropins also. Similar poor responsiveness
to LH-Releasing Hormone was present.
A greater percentage of patients who had rapid
weight gain had normal estrogenization. baseline
gonadotropins. and normal LH-Releasing Hormone
response.
Patients with stable weight who were felt lo have
hypothalamic amenorrhea were basically normal in
estrogenization and baseline gonadotropins. All
patients had at least some response lo LH-Releasing
Hormone, and five had excessive responses. Patients
who developed amenorrhea after using oral con
traceptives were similar.
The 26 patients with hypothalamic amenorrhea,
as a group, were better estrogenized, had more nor
mal gonadotropins, and responded more normally or
excessively to LH-Releasing Hormone than did <he
patients with anorexia nervosa or patients with
organic causes of secondary amenorrhea.
0/igomenorrhea. Four patients had oligo
menorrhea, two with evidence of ovarian androgen
excess. Baseline estrogen, gonadotropins, and

other hormone testing were normal except for one
patient who was hypothyroid and two hirsute
patients in whom there were elevated 17-ketosteroids
and serum testosterone. All four patients had positive
responses to LH-Releasing Hormone. although in
two of these patients the response of LH was
borderline. All patients had normal responses to
lnsulin-HGH and Metopirone®.
Summary of Studies. In an attempt to summarize
these diagnostic studies, one can draw the following
conclusions from this group of 58 amenorrheic
women:
Skull x-rays are very useful, if positive.
Physical examination is useful when obvious
signs of endocrinopathy are present, including
acromegaly. hypopituitarism. galactorrhea. or signs
of androgen excess. Negative findings do not exclude
significant organic pathology, however. Findings
suggesting deficiency of a "target gland" (for
example, adrenal, thyroid) may be reflections of
pituitary-hypothalamic dysfunction rather than peri
pheral gland abnormality.
Patients with organic causes of amenorrhea are
more likely lo have clinical hypoestrogenism. and it
will lend lo be more severe than in patients with
"functional" or nonorganic causes. The exception is
anorexia nervosa. certainly a severe functional dis
order.
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FI UR E I
G
AMENORRHEA
OUTPATIENT EVALUATION

Thyroid
Adrenal

H,. Physical and Pelvic Exams
Maturation Index
Endometrial Biopsy
CBC. Urinalysis. Chem.
Skull ,-ray

170H. 17KS
FSH
Thyroid T,. T,
Progesterone;: Tcsl
Visual Fields

l l l

Andrugcn

1-a i lclJ

Ovary

SUSPECTED
HYPOPtTUlTARISM

Baseline serum FSH is of use in identifying
gonadal failure. or dysgenesis. when FSH is very
high. 1 n problems of androgen excess and functional
causes of primary amenorrhea. LH seems likely to be:
slightly elevated with FSH normal. Gonadotropins
are low in patients both with central organic causes
and with the more severe functional causes of this
problem.
Baseline measurements of growth hormone.
prolactin. 17-hydroxycorticoids and 17-ketosteroids.
and thyroid hormone all are of great use if ab
normal, but usually will require further evaluation.
Testing with LH-Releasing Hormone does
provide useful information. Patients with organic
causes of amenorrhea, other than gonadal failure or
androgen excess. were more likely to respond poorly
to LH-Releasing Hormone: however. a signiticant
proportion of these patients showed some response:
with regard to LH, or FSH, or both gonadotropins.
Patients with functional disorders more likely had
normal or excessive response to LH-Releasing Hor
mone while those classified as having more severe
functional disorders responded very poorly. Growth

hormone testing with insulin and Metopirone® test
ing were of relatively little diagnostic aid unless a
major organic etiology was present; an etiology
likely demonstrable on skull x-rays. clinical ex
amination. or in patients with more severe ab
normalities in baseline hormonal testing.
We would again emphasize that these are only
!rends in the results of diagnostic studies in patients
who present with amenorrhea. Larger group studies
are needed to evaluate the full statistical significance
of these data. We would also again emphasize the
need for a thoughtful. individualized. sequential
evaluation of each patient who presents.
Comment. To reach the goal of individualization
in the evaluation of the amenorrheic patient we
suggest several possibilities:
Figure I illustrates what we consider an ade
quate screening study for the amenorrheic patient
which usually can be done in the outpatient setting.
Based on these results. and the clinical tindings pres
ent. one can categorize problems under thyroid,
adrenal. ovarian androgen. or gonadal failure for
further studies which can usually be done in the out-

E

G
I' T

i

l l l

SUSPECTED HYPOPITUITARISM

INPATIENT STUDY

Baseline: FSH, LH. Prolactin. Estrogen. Growth Hormone
Metopirune" Test (")
Insulin-Induced Hypoglycemia Growth Hormone Test('')
LH-Releasing Hormone Test (A Y 24031)

l l l

"SUSPICIOUS"

"Fundiunal"

Follow-up
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the adequate endocrinologic work-up of the
amenorrheic patient.

E

1

l l l

.. SUSPICIOUS" HYPOPITUITARISl\1

2ND INPATIENT STUDY
If Prolactin-L-Dopa test: Chlorprom,.11inc tc:-.l. \Vatc.:r load
Pneumoenceph�1 logram
Carotid Arteriogram

THERAPY
(Medical. Surgical. Irradiation)

patient setting. Some patients will have suspected
hypopituitarism and require hospitalization for
further study.
Patients with the problem of suspected hypo
pituitarism should undergo further testing (Fig.
2) as evidenced by the preliminary studies. which
should at least include baseline hormonal testing and
testing with LH-Releasing Hormone. Growth hor
mone testing with insulin and/or Metopirone"
testing may be indicated. but this must be individ
ualized. Patients who are felt to have "functional"
disorders causing amenorrhea are begun on appro
priate therapy or follow-up, while patients who are
strongly suspected of hypopituitarism usually are
studied further.
Further studies (Fig. 3) include tests such as
prolactin kinetics. pneumoencephalogram. and
possibly arteriogram. If pituitary tumor. cranio
pharygioma. or other etiology of hypopituitarism is
found. then appropriate medical. surgical. or irradia
tional therapy is initiated.
In this fashion we have tried to present to you
the summation of data in 58 patients who presented
with amenorrhea. and the endocrinologic testing
results that have led to the <::stablishment of a
diagnosis. Again. it should be stressed that a
systematic. individualized work-up is mandatory for
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